Flexibility is the Key to Data Acquisition for Rare Disease Trials
Veristat explores the reasons why rare disease clinical development often requires flexibility in data management and database design.
Extending our scientific depth across allergy, dermatology, ophthalmology, respiratory, women's health, and more.
Factors such as ongoing industry consolidation, continual regulatory change, rapid technology evolution, and unending cost-cutting are causing organizations to consider replacing or upgrading their existing Electronic Data Capture (EDC) solution.
The roadmap for migrating from one application to another does not have to be so overwhelming if you bring knowledge, experience, and methodology to the project. Data migration became necessary in this case from a proprietary EDC system to another solution due to the limited built-in functions of the old solution.
Hear two of our expert database programmers discuss why and how they migrated data between Electronic Data Capture systems. Hear them wall through key learning objectives, including:
Meet Veristat. Learn More.
Veristat explores the reasons why rare disease clinical development often requires flexibility in data management and database design.
Data Monitoring Committees (DMCs) play a vital role in clinical trials by providing independent oversight to ensure patient safety, maintain...
Are Your Clinical Datasets Submission Ready?